Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Pre-close Trading Statement

3 Apr 2008 07:00

Marston's PLC03 April 2008 3 April 2008 Marston's PLC Pre-Close Trading Statement The Board of Marston's PLC issues the following trading update following the endof the first half of the current financial year on 29 March 2008. Trading In Marston's Inns & Taverns, our managed pub division, like-for-like sales forthe 24 weeks to 15 March 2008* were 0.3% above last year against strongcomparatives, with reported like-for-like sales growth of 7.0% for the sameperiod last year. Food sales have continued to show excellent like-for-likesales growth of 7.8% in the same 24 week period, although higher margin wetsales and machine income were 3.1% and 10.3% below last year respectively. Ournew build programme continues to generate attractive returns with 8 new pubsopened in the first half-year, and we expect to open a further 12 in the secondhalf-year. In Marston's Pub Company, our tenanted and leased pub division, like-for-likeprofit was slightly below last year in the period with growth in rental incomeoffset by volumes and machine income in line with market trends. In Marston's Beer Company, whilst overall volumes remain below last year we haveincreased market share with continued good performance in the premium alesegment. Costs across the Group have been well controlled, notwithstanding inflationarypressures in brewing and food purchasing, but the changes in sales mix describedabove will continue to have an impact on operating margins. In our interim results statement due to be issued on 23 May 2008 we expect toreport Group sales up by around 4% compared to last year for the 26 week period,reflecting the acquisitions of Sovereign Inns, Eldridge Pope and RingwoodBrewery in 2007. Operating profit (before interest and taxation) is expected tobe in line with last year, although profit before taxation will reflect thehigher interest costs associated with the £150 million share buy-back programmein 2007. Earnings per share will also reflect the related reduction of around9.5% in the average number of shares in issue and an expected lower underlyingrate of taxation. Underlying cash generation remains strong with net debtestimated to be approximately £1.27 billion at the half year-end. Outlook We remain cautious about the outlook for 2008, and the recent increase in beerduty adds to the pressures on tenants and free trade operators in an alreadychallenging trading environment. However with our high quality pub estate and our continuing investment innew-build pubs, we are well positioned to exploit favourable trends includingmarket growth in casual dining, and our value for money offers and mid-marketposition are well suited to the current economic climate. Notwithstanding thecurrent testing market conditions our expectations for the financial year as awhole remain unchanged. * In 2007 Easter fell in the second half-year. Like-for-like sales are reportedfor the 24 week period in order to be on a comparable basis to last year. ENQUIRIES:Marston's, PLC Hudson SandlerRalph Findlay, Chief Executive Andrew HayesPaul Inglett, Finance Director Nick LyonTel: 01902 329516 James White Tel: 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector Declaration
18th Dec 20194:28 pmRNSAnnual Financial Report
12th Dec 20193:52 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSPreliminary Results
25th Nov 20197:00 amRNSCompletion of Disposal
21st Nov 20192:52 pmRNSDirectorate Change
4th Nov 20197:00 amRNSDisposal
1st Nov 20192:24 pmRNSTotal Voting Rights
15th Oct 20197:00 amRNSYear End Trading Update
1st Oct 201910:05 amRNSTotal Voting Rights
2nd Sep 20192:15 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSBoard Changes
24th Jul 20197:00 amRNSTrading Update
10th Jul 201911:15 amRNSBlock listing Interim Review
17th Jun 20193:37 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSInterim results for 26 weeks ended 30 March 2019
4th Mar 201911:51 amRNSTotal Voting Rights
1st Feb 20199:11 amRNSTotal Voting Rights
24th Jan 201910:29 amRNSResult of AGM
23rd Jan 20197:00 amRNSTrading Update for the 16 weeks to 19 January 2019
11th Jan 20198:48 amRNSBlock listing Interim Review
2nd Jan 20192:20 pmRNSTotal Voting Rights
19th Dec 201811:04 amRNSAnnual Financial Report
13th Dec 20183:09 pmRNSDirector/PDMR Shareholding
13th Dec 20183:07 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSPreliminary Results
8th Nov 20188:46 amRNSHolding(s) in Company
6th Nov 20184:19 pmRNSHolding(s) in Company
2nd Nov 20182:39 pmRNSHolding(s) in Company
1st Nov 20183:35 pmRNSHolding(s) in Company
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company
10th Oct 20187:00 amRNSYEAR END TRADING UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.